Browse stocks · Browse sectors · Healthcare · Healthcare · Pharmaceuticals & Biotechnology · Pharmaceuticals

NSE RESEARCH WORKSPACE

Biocon Ltd

NSE: BIOCON

OverviewFinancial StatementsQuant ScoreForensic Accounting+

Price1Y

Company Overview

Biocon Ltd is classified in Pharmaceuticals.

Market Cap: ₹ 52,720.61 Cr.
Price in snapshot: ₹ 323.5
ROE: 1.33 %
ROCE: 3.38 %
Dividend Yield: 0.15 %

Snapshot updated 18 October 2026. Figures are not live quotes.

Research coverage

Concall documents: transcript for Q1 FY27, dated 11 August 2026.
Annual-report coverage: FY2026.
Company exchange-filing catalog coverage.

Browse concall documents · Browse exchange filings